Document Detail

Impact of amiodarone on electrophysiologic properties of pulmonary veins in patients with paroxysmal atrial fibrillation.
MedLine Citation:
PMID:  15673385     Owner:  NLM     Status:  MEDLINE    
INTRODUCTION: Pulmonary veins (PVs) are the predominant location of triggers for atrial fibrillation (AF), but little is known about the electrophysiologic properties of PVs. In addition, the influence of amiodarone on the electrophysiologic properties of PVs has not been elucidated. METHODS AND RESULTS: Fifty-five patients with symptomatic and drug-resistant AF were divided into two groups: group 1 patients (n=29) without antiarrhythmic drug therapy at the time of electrophysiologic study (EPS), and group 2 patients (n=26) undergoing continuous long-term treatment with amiodarone. EPS including programmed stimulation of both atria and within the PVs was performed in both groups. In group 1, the effective refractory period (ERP) of all PVs (174 +/- 62 msec) was significantly shorter than the ERP of the left atrium ([LA] 254 +/- 30 msec, P=0.0001) and right atrium ([RA] 221 +/- 29 msec, P=0.0001). The same pattern was observed in group 2 (PV: 210 +/- 58 msec; LA: 259 +/- 35 msec, P=0.0001; RA: 246 +/- 37 msec, P=0.0255). The ERP of all stimulated PVs was significantly lower in group 1 (174 +/- 62 msec) than in group 2 (210 +/- 58 msec; P=0.0001). The ERP of the left superior and right superior PVs and RA but not the left inferior PV and LA were significantly increased in patients treated with amiodarone. Decremental conduction properties were observed in all stimulated PVs, and there were no significantly differences between the maximal decrement of both groups. CONCLUSION: The distinctive electrophysiologic properties of PVs are emphasized by amiodarone therapy. Long-term amiodarone treatment is responsible for heterogeneous alteration of the PV electrophysiology, which may account for the individual antiarrhythmic responses in a subset of patients with paroxysmal AF.
Thomas Rostock; Helge Servatius; Tim Risius; Rodolfo Ventura; Christian Weiss; Thomas Meinertz; Stephan Willems
Related Documents :
9382005 - Natural history of left atrial spontaneous echo contrast in nonrheumatic atrial fibrill...
17115325 - The prognostic impact of successful cardioversion of atrial fibrillation in patients wi...
12845335 - Dofetilide: a new antiarrhythmic agent approved for conversion and/or maintenance of at...
15175055 - On the atrial response to focal discharges in man.
2889615 - Identical twin marrow transplantation for 5 patients with chronic myeloid leukaemia: ro...
16399965 - Patient- and facility-level factors associated with diffusion of a new antipsychotic in...
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  Journal of cardiovascular electrophysiology     Volume:  16     ISSN:  1045-3873     ISO Abbreviation:  J. Cardiovasc. Electrophysiol.     Publication Date:  2005 Jan 
Date Detail:
Created Date:  2005-01-27     Completed Date:  2005-04-28     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9010756     Medline TA:  J Cardiovasc Electrophysiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  39-44     Citation Subset:  IM    
Department of Cardiology, University Hospital Eppendorf, Hamburg, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Amiodarone / administration & dosage*
Anti-Arrhythmia Agents / administration & dosage
Atrial Fibrillation / drug therapy*,  physiopathology*
Heart Conduction System / drug effects*,  physiopathology*
Heart Rate / drug effects
Middle Aged
Pulmonary Veins / drug effects*,  physiopathology*
Refractory Period, Electrophysiological / drug effects
Treatment Outcome
Reg. No./Substance:
0/Anti-Arrhythmia Agents; 1951-25-3/Amiodarone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pace mapping of Koch's triangle reduces risk of atrioventricular block during ablation of atrioventr...
Next Document:  Assessment of markers for identifying patients at risk for life-threatening arrhythmic events in Bru...